Malignant Peripheral Nerve Sheath Tumors Clinical Trials
3 recruiting trials for Malignant Peripheral Nerve Sheath Tumors. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06515860
Neurofibromatosis Type 1 Tumor Early Detection Study
The goal of this observational study is to determine if a liquid biopsy (i.e. blood test) is an effective clinical tool for monitoring the development of malignant peripheral...
Sponsor: David MillerEnrolling: 10001 location
RECRUITINGNCT03141021
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor...
Sponsor: Washington University School of MedicineEnrolling: 105013 locations
RECRUITINGPhase 1NCT05245500
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid...
Sponsor: Bristol-Myers SquibbEnrolling: 33620 locations